Nanomedicine and Nanoscale Delivery (Focus Group – NND)
Evelina Fassina
PhD Student
University of Turin
San Giorgio Canavese, Italy
Versatile drug delivery platforms capable of adapting to multiple biological contexts are urgently needed in nanomedicine. Conventional nanocarriers are often application-specific, limiting versatility and applicability in different complex biological environments such as mucosae or infected tissues1. Here, we introduce mucosomes2, bioinspired glycosylated nanoparticles based on the main component of mucus (mucins) that act as bioactive interfaces, enabling both transmucosal drug delivery and medical device functionalization across distinct therapeutic contexts.